Stefan Andreas Abele - 18 Mar 2026 Form 3 Insider Report for Pharvaris N.V. (PHVS)

Role: Chief Technical Ops Officer
Signature: /s/ Marnus Nel, Attorney-in-Fact for Stefan Abele
Issuer symbol: PHVS
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 14:23:32 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Abele Stefan Andreas	Chief Technical Ops Officer	1 CRANBERRY HILL SUITE 400, LEXINGTON	/s/ Marnus Nel, Attorney-in-Fact for Stefan Abele	18 Mar 2026	0002002390

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PHVS	Common Stock						43,942	18 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PHVS	Stock Option (Right to Buy)							18 Mar 2026	Common Stock	60,000	$28.00	Direct	F2
holding	PHVS	Stock Option (Right to Buy)							18 Mar 2026	Common Stock	60,000	$16.05	Direct	F3
holding	PHVS	Stock Option (Right to Buy)							18 Mar 2026	Common Stock	40,000	$22.31	Direct	F4
holding	PHVS	Stock Option (Right to Buy)							18 Mar 2026	Common Stock	89,500	$16.40	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted stock units previously granted under the Company's equity plan that remain outstanding as of March 18, 2026. The awards settle in shares of common stock and are reported in Table I as non-derivative securities. Vesting occurs as follows: -20,000 RSUs from an award granted March 3, 2026 of which 25% vested March 3, 2027 with the remainder vesting monthly thereafter; -15,000 RSUs from an award granted March 12, 2025 of which 25% vested March 12, 2026 with the remainder vesting monthly thereafter; -6,849 RSUs from an award granted April 11, 2024 of which 25% vested April 11, 2025 with the remainder vesting monthly thereafter.
F2	25% of the option will vest on March 3, 2027 with the remaining shares vesting in 1/48 monthly installments thereafter.
F3	25% of the option vested on March 12, 2026 with the remaining shares vesting in 1/48 monthly installments thereafter.
F4	25% of the option vested on April 11, 2025 with the remaining shares vesting in 1/48 monthly installments thereafter.
F5	25% of the option vested on November 15, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.